Nrc Health (NRC) Stock Price & Analysis
Nrc Health (NRC) rose 2.17% to USD 19.75 as of June 10, 2026 at 02:34 UTC, according to Nexqual real-time market data.
NRC last closed at USD 19.33; the session ranged USD 19.36–20.09 on volume of 163,475 shares. Market capitalization is $445.10M, with a 52-week range of USD 11.01–22.79 (NMS). Source: Nexqual, June 10, 2026 at 02:34 UTC.
Key Statistics (as of June 10, 2026 at 02:34 UTC)
| Price | USD 19.75 |
|---|---|
| Change | ▲ 2.17% (up) |
| Previous Close | USD 19.33 |
| Open | USD 19.57 |
| Day Range | USD 19.36 – 20.09 |
| 52-Week Range | USD 11.01 – 22.79 |
| Volume | 163,475 shares |
| Market Cap | $445.10M |
| Exchange | NMS |
Technical Analysis (NRC)
Nexqual's technical model rates NRC "STRONG BUY" based on 5 bullish and 0 bearish signals across 124 daily candles, as of June 10, 2026 at 02:34 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 58.21 (neutral) |
| vs SMA50 | Above (USD 18.17) |
| MACD | 0.41 (positive) |
Analyst Ratings (NRC)
Wall Street analysts rate NRC "None", per Nexqual as of June 10, 2026 at 02:34 UTC.
| Consensus Rating | None |
|---|
Earnings (NRC)
| Next Earnings Date | 2026-07-27 |
|---|
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2019-06-30 | USD 0.29 vs est 0.26 ▲ beat |
| 2019-03-31 | USD 0.32 vs est 0.31 ▲ beat |
| 2018-12-31 | USD 0.3 vs est 1.05 ▼ miss |
| 2018-09-30 | USD 0.27 vs est 0.98 ▼ miss |
Source: Nexqual, June 10, 2026 at 02:34 UTC.
Financials & Fundamentals (NRC)
| Total Revenue | $138.64M |
|---|---|
| Revenue Growth (YoY) | +3.70% |
| Gross Margin | +61.80% |
| Operating Margin | +16.00% |
| Profit Margin | +6.52% |
| ROE | +41.86% |
| Debt / Equity | 578.23 |
| Current Ratio | 0.52 |
| Total Cash | $2.55M |
| Total Debt | $78.03M |
| Free Cash Flow | $19.73M |
Source: Nexqual, June 10, 2026 at 02:34 UTC.
Financial Health Score (NRC)
Nexqual rates Nrc Health's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 02:34 UTC.
| Growth | Mixed — Revenue +1.8% YoY (annual), slow |
|---|---|
| Profitability | Strong — Gross margin 62%, operating 16% |
| Balance Sheet | Critical — $3M cash vs $78M debt |
| Cash Flow | Strong — FCF $20M, 16% margin |
| Efficiency | Strong — ROE 42%, ROA 12.2% |
Ownership (NRC)
| Insider Ownership | +48.96% |
|---|---|
| Institutional Ownership | +49.67% |
| Shares Outstanding | 22.54M |
| Float | 11.98M |
| Short % of Float | +16.52% |
Source: Nexqual, June 10, 2026 at 02:34 UTC.
Leadership (NRC)
Nrc Health is led by Trent S. Green (age 53), CEO, Principal Executive Officer & Director, per Nexqual as of June 10, 2026 at 02:34 UTC.
| CEO, Principal Executive Officer & Director | Trent S. Green (age 53) |
|---|---|
| Founder & Chairman | Michael D. Hays (age 70) |
| Executive VP, CFO, Treasurer & Secretary | Shane R. Harrison (age 48) |
| EVP & COO | Helen L. Hrdy (age 60) |
| Executive Vice President of Sales | Jason R. Rau (age 54) |
Major Backers & Investors (NRC)
Notable institutional backers of Nrc Health include Kayne Anderson Rudnick Investment Management LLC, Virtus Equity Trust-Virtus KAR Small-Cap Growth Fund, Morgan Stanley, according to Nexqual as of June 10, 2026 at 02:34 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Kayne Anderson Rudnick Investment Management LLC | 11.7% |
| Virtus Equity Trust-Virtus KAR Small-Cap Growth Fund | 7.58% |
| Morgan Stanley | 4.45% |
| QV Investors Inc. | 1.69% |
| Renaissance Technologies | 1.51% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 6.03% |
| Vanguard Group | 5.8% |
| Dimensional Fund Advisors | 2.17% |
| Geode Capital | 1.75% |
| State Street | 1.33% |
Source: Nexqual, June 10, 2026 at 02:34 UTC.
From Nrc Health's Latest SEC 10-K Filing (filed 2026-03-05)
Key Strengths & Strategy (as disclosed to the SEC)
- NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States.
- The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, and behaviors of communities through assessments.
- It also provides patient experience solutions, a cross-continuum multi-mode digital platform that collects and measures data to improve patient experience, engagement, and loyalty; employee experience solutions, which combines health care with technology comprising engagement, pulse, lifecycle, culture of safety, and magnet RN satisfaction; and consumer experience solution that offers online reputation solutions, community insights, and cross-journey listening through nGage.
- In addition, the company offers Huey, an AI engine built for Human Understanding that serves as a healthcare experience management companion; and governance solutions provided through national conferences, publications, advisory services, and an online portal for not-for-profit health system boards of directors, executives, and physician leadership.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| OFLX | Omega Flex, Inc. | USD 31.18 | ▲ 3.42% |
| NODK | NI Holdings, Inc. | USD 15.21 | ▲ 2.29% |
| VREX | Varex Imaging Corporation | USD 10.62 | ▲ 5.25% |
| CNXN | PC Connection, Inc. | USD 73.28 | ▲ 1.57% |
| MLAB | Mesa Laboratories, Inc. | USD 109.03 | ▲ 4.95% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:34 UTC. This page is informational and not investment advice.